UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy

Mariot, Virginie; Dumonceaux, Julie; (2022) Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy. Frontiers in Genome Editing , 4 , Article 937879. 10.3389/fgeed.2022.937879. Green open access

[thumbnail of Mariot_Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy_VoR.pdf]
Preview
PDF
Mariot_Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy_VoR.pdf - Published Version

Download (1MB) | Preview

Abstract

Facioscapulohumeral dystrophy (FSHD) is a skeletal muscle disease caused by the aberrant expression of the DUX4 gene in the muscle tissue. To date, different therapeutic approaches have been proposed, targeting DUX4 at the DNA, RNA or protein levels. The recent development of the clustered regularly interspaced short-palindromic repeat (CRISPR) based technology opened new avenues of research, and FSHD is no exception. For the first time, a cure for genetic muscular diseases can be considered. Here, we describe CRISPR-based strategies that are currently being investigated for FSHD. The different approaches include the epigenome editing targeting the DUX4 gene and its promoter, gene editing targeting the polyadenylation of DUX4 using TALEN, CRISPR/cas9 or adenine base editing and the CRISPR-Cas9 genome editing for SMCHD1. We also discuss challenges facing the development of these gene editing based therapeutics.

Type: Article
Title: Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3389/fgeed.2022.937879
Publisher version: https://doi.org/10.3389/fgeed.2022.937879
Language: English
Additional information: © 2022 Mariot and Dumonceaux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).
Keywords: CRISPR, DUX4, FSHD, TALEN, cas9, gene editing, muscle, therapy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10160176
Downloads since deposit
42Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item